Sunday, April 26, 2020 12:59:41 PM
From PRs:
3/11 “We anticipate the sale of 420,000,000 kits in the first full year of commercial sale.”
3/16 – “We expect the vast majority of the 420 million test kits we plan to manufacture in the first year of production will be sold to individuals for self-testing."
3/17 “We are happy to inform all interested parties that we have raised our 12-month forecast to 525 million kits.”
His final clarification was on 4/23:
"While the FDA assesses how to move forward with this technology, the company is moving to work with a large health care products distributor who has already received requests for the GenViro! Swift kits. Outlets ranging from Fortune 50 corporations to professional sports leagues have shown strong interest. The company estimates it will be asked to produce 1 million "Swift Kits" per month through the end of the year just for the "back to work" markets, based on the rapidly building demand."
Notice: 1M/month = much reduced = adjusted
estimates
anticipate
expect
plan
forecast
NOWHERE does he use the word will
The ONLY question is: did they have or would they have manufacturing capability/access to back up those numbers?
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM